|
|
|
|
|
|
By Nathan Parker, principal consultant, Parker Biopharmaceutical Consulting | The COVID-19-era guidance is designed to help manufacturers make container closure system changes quickly when facing supply constraints. It may be useful when evaluating risks beyond the pandemic. |
|
|
|
| Better Therapeutic Outcomes From Better Drug Delivery | Q&A | Celanese | Innovative drug-eluting implants, inserts, and transdermal films delivering biologics and small molecules can meet the goals of patient-centric therapies, improved medicine, and better healthcare economics. |
|
|
| Container Closure Integrity Testing: Risks And Methods | Application Note | By Dennis Seibert, Pfeiffer Vacuum Inc. | We share an overview of integrity tests where high sensitivity is required to prevent the risks of stability failure of highly moisture-sensitive drugs or biological ingress of sterile parenteral drugs. |
|
|
|
| AVV Manufacturing Platform To Produce Safer Vaccines Cheaper | Poster | By K. Vrabec, H. Jug, A. Mavri, I. Petrovic Koshmak, V. Fujs, M. Leskovec, and A. Štrancar, Sartorius | In this study, we present a second-generation purification procedure for adenoviral vectors based on monolith chromatography that secures safer products and enhances purity at higher yields. |
|
|
|
|
|
|
| The Aqueous Cleaning Handbook | e-book | By Michael Moussourakis, Jeff Phillips, Stacy Silverstein, and Malcolm McLaughlin, Alconox Inc. | This handbook is intended to assist laboratory and manufacturing plant scientists and engineers in accurately selecting and maximizing the performance of aqueous cleaners and systems. |
|
|
|
|
| A Gene Expression System For Afucosylated Antibody Production | Poster | By Qi Liu, Bernie Sweeney, and Marc Feary, Lonza | Use a gene expression system that allows you to produce molecules that are 100% free of fucose and demonstrate increased potency, without compromising on titers, growth, stability, or product quality. |
|
|
| Elastomer Plungers With Barrier Film For COVID-19 Vaccines | Article | By Amy A. Kim and T. Page McAndrew, Ph.D., West Pharmaceutical Services, Inc. | Minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with the use of an elastomer plunger laminated with FluroTec™ barrier film. |
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|